MyAverix Finance MyAverix Finance

US

CERo Therapeutics Holdings Inc (CEROW)

CERo Therapeutics Holdings Inc (CEROW) is listed on US. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-23

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for CEROW

P/E ratio
18.00

CERo Therapeutics Holdings Inc (CEROW) — FAQ

What is CEROW's P/E ratio?

The price-to-earnings (P/E) ratio for CERo Therapeutics Holdings Inc (CEROW) is 18.00 (data as of 2026-05-23).

Does CERo Therapeutics Holdings Inc pay a dividend?

Dividend yield is not available in the current snapshot for CERo Therapeutics Holdings Inc (CEROW). Check the MyAverix Finance app for the latest dividend data.

What exchange is CEROW listed on?

CEROW is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play